Search

everythinglearnresearchcommunity

for

Search:↓

Getting ethical approval for research with children is important but can be complex and time-consuming, sometimes leading to the exclusion of certain age groups.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

Getting insurance to cover the hair loss treatment tofacitinib is hard because it's not officially approved for that use.

A new acne cream effectively reduced acne in trials and awaits FDA approval.

LLLT devices for hair loss need more research to define proper guidelines.

The FDA rejected a testosterone drug again due to safety concerns.

The FDA did not approve a testosterone drug because of safety concerns.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

Some drugs have gained approval for new uses, while others like tricyclic antidepressants and aspirin show promise but aren't yet approved for these uses.

More profitable TV stations have stricter ad approval rules, and bigger stations are generally stricter too.

The ISHRS received high-level approval for its educational programs.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Restolin Hair Supplement may help hair growth but lacks FDA approval and clinical trial evidence.

The document warns against US clinics selling untested stem cell treatments without FDA approval.

The US and EU lead in cell and gene therapy regulations with more approvals and clinical trials, while India is in early stages with fewer approvals and expedited processes.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

Thermoresponsive nanogels show promise for delivering medicine through the skin but need more safety testing and regulatory approval before clinical use.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Topical finasteride is promising for hair loss with minimal side effects but needs more research and approval.

Drug repurposing speeds up drug development, saves money, and has led to about a third of new drug approvals.

In June 2019, the stem cell research field saw major progress, including new clinical trials, FDA approvals, and industry collaborations.

Low-Level Laser Therapy is effective and safe for hair growth with minimal side effects.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

Japan improved its regulation of regenerative medicine to ensure safety and prevent unproven treatments.

Laser hair transplantation can be effective but should be limited to small areas and requires more training to ensure safety and effectiveness.

Maintaining sexual health after menopause is possible with patient approaches, hormone supplements, and therapy, despite needing more research.

HS patients rarely see dermatologists, often get opiates, and need better care.

Baricitinib effectively promotes long-term hair regrowth in alopecia areata patients.